Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589459 · ClinicalTrials.gov registry record
Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 103
- Enrollment target
NCT00589459 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 103 participants.
The verdict
NCT00589459 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Unit 6-8 weeks after hospital discharge for an oral glucose tolerance test to identify individuals with pre-diabetes and diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2001-10-01 |
| Est. Completion | 2008-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589459
The ClinicalTrials.gov registry entry for NCT00589459 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00589459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589459 about?
NCT00589459 is a clinical study titled "Gender Differences in Prevalence of Undiagnosed Diabetes in ACS". The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Un...
What is the current status of trial NCT00589459?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2001-10-01. Estimated completion is 2008-12-01.
Who is sponsoring clinical trial NCT00589459?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.